@article{0f9879cdb2e94e9d8107cfc35d1ff50a,
title = "Phase I dose-escalation and pharmacokinetic study of dasatinib in patients with advanced solid tumors",
abstract = "To determine the maximum tolerated dose, dose-limiting toxicity (DLT), and recommended phase II dose of dasatinib in metastatic solid tumors refractory to standard therapies or for which no effective standard therapy exists.",
author = "Demetri, {George D} and {Lo Russo}, Patricia and MacPherson, {Iain R J} and Ding Wang and Morgan, {Jeffrey A} and Brunton, {Valerie G} and Prashni Paliwal and Shruti Agrawal and Maurizio Voi and Evans, {T R Jeffry}",
year = "2009",
doi = "10.1158/1078-0432.CCR-09-0224",
language = "English",
volume = "15",
pages = "6232--40",
journal = "Clinical Cancer Research",
issn = "1078-0432",
publisher = "American Association for Cancer Research Inc.",
number = "19",
}